<DOC>
	<DOCNO>NCT03066622</DOCNO>
	<brief_summary>This trial prospective , randomize , feasibility trial primary aim compare well oral rapidly dissolve olanzapine control primary headache pain compare current treatment strategy use emergency department often require intravenous intramuscular medication .</brief_summary>
	<brief_title>Olanzapine Acute Headaches</brief_title>
	<detailed_description>Primary Question : Does oral rapidly dissolve olanzapine provide efficacious analgesia patient acute headache non-organic origin ( primary headache ) come ED abortive therapy compare current standard care ? Secondary Aim : Additionally , study aim see oral rapidly dissolve olanzapine decrease 1 ) duration ED length stay 2 ) need IV access compare current standard care . This prospective , randomize , convenience sample , feasibility trial test non-inferiority oral rapidly dissolve olanzapine versus current emergency department standard care provide symptomatic relief patient present primary headache .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1 . Adult patient 1865 year age present emergency department acute primary headache 2 . Patient approve inclusion primary attend physician emergency department 1 . Age &lt; 18 &gt; 65 2 . Pregnancy 3 . Known allergy olanzapine 4 . Known QT prolongation underlie condition place patient risk QT prolongation 5 . Inability give write consent ( intoxication , alter mental status ) 6 . Headache organic origin ( trauma , infection , previous recent head neck surgery ) 7 . Patient already prescribe daily olanzapine outpatient basis 8 . Patient administer olanzapine within past 24 hour 9 . Language barrier</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>